Suono Bio
Year
2016
Area
Healthcare and Medical
![](https://deshpande.mit.edu/wp-content/uploads/2021/11/Screen-Shot-2021-11-22-at-5.22.25-PM-580x360-c-default.jpg)
Suono Bio is working to revolutionize what therapeutics may be used to treat diseases.
Advances in genomics have enabled a step-shift in our understanding of diseases and relevant targets to treat those diseases, but delivery technologies lag. Suono is developing potentially superior therapies, like nucleic acids and gene therapies, in a simplified proprietary formulation. The company aims to enable the use of the right drug at the right location in the right patient.
![](https://live-mit-deshpande.pantheonsite.io/wp-content/uploads/2022/01/MIT-Suono-Bio-01-press_0.jpg)
Enabling the oral delivery of macromolecules: The ultrasound pill
Suono is a spinout from the 2011 project, Enabling the oral delivery of macromolecules: The ultrasound pill.
![](https://live-mit-deshpande.pantheonsite.io/wp-content/uploads/2021/11/News-default.png)
Enhancing drug delivery with ultrasound
Suono Bio, co-founded by MIT alumnus Carl Schoellhammer and two MIT professors, uses ultrasound waves to deliver drugs to the gastrointestinal tract.